SaGAS, the Short and Graphic Ability Score: An alternative scoring method for the motor components of the Multiple Sclerosis Functional Composite

Multiple Sclerosis

Volumn 10, Issue 2, 2004, Pages 231-242

  Vaney, Claude ^a   Vaney, S ^b   Wade, D T ^c  

^a Berner Klinik   (Switzerland)

^b EPFL   (Switzerland)

^c OXFORD CENTRE FOR ENABLEMENT   (United Kingdom)

Author keywords

EDSS; MSFC; Multiple sclerosis; Nine hole peg test; Timed 10 m walk

Indexed keywords

ADULT; AGED; ARTICLE; CONTROLLED STUDY; CORRELATION COEFFICIENT; DAILY LIFE ACTIVITY; FOLLOW UP; HAND MOVEMENT; HUMAN; INDEPENDENCE; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MATHEMATICAL COMPUTING; MOBILIZATION; MOTOR PERFORMANCE; MULTIPLE SCLEROSIS; NOMOGRAM; PHYSICAL CAPACITY; PHYSICAL DISABILITY; PHYSIOTHERAPY; PSYCHOMETRY; RATING SCALE; SCORING SYSTEM; SENSITIVITY ANALYSIS; STATISTICAL ANALYSIS; TASK PERFORMANCE; TIME; WALKING; WALKING SPEED;

ACTIVITIES OF DAILY LIVING; ADULT; AGED; DISABILITY EVALUATION; FOLLOW-UP STUDIES; HUMANS; MIDDLE AGED; MODELS, THEORETICAL; MOTOR ACTIVITY; MULTIPLE SCLEROSIS; OUTCOME ASSESSMENT (HEALTH CARE); PSYCHOMETRICS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX;

EID: 16544395825     PISSN: 13524585     EISSN: None     Source Type: Journal    
DOI: 10.1191/1352458504ms1000oa     Document Type: Article

References (27)

1. European Study Group on Interferon β-1b in Secondary Progressive MS. Placebo-controlled multicentre randomised trial of interferon β-1b in the treatment of secondary progressive multiple sclerosis. Lancet 1998; 352: 1491-97.
2. Kurtzke JF. Rating neurological impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 1983; 33: 1444-52.
3. Whitaker JN, Mc Farland HF, Thompson AJ, Hobart CH. Multiple sclerosis: assessment of disability and disability scales. J Neurol 1998; 245: 189-96.
4. Rudick R, Antel J, Confavreux C, Cutter G, Ellison G, Fischer J et al. Recommendation from the National Multiple Sclerosis Society Clinical Outcome Assessment Task Force. Ann Neurol 1997; 42: 379-82.
5. Cutter GR, Baier ML, Rudick RA, Cookfair DL, Fischer JS, Petkau J et al. Development of a multiple sclerosis functional composite as a clinical trial outcome measure. Brain 1999; 122: 871-82.
6. Uitdehaag BMJ, Ader HJ, Roosma TJA, de Groot V, Kalkers NF, Polman CH. Multiple sclerosis functional composite: impact of reference population and interpretation of changes. Mult Scler 2002; 8: 366-71.
7. Cohen JA, Fischer JS, Bolibrush DM, Jak AJ, Kniker JE, Mertz LA et al. Intrarater and interrater reliability of the functional composite measure. Neurology 2000; 54: 802-806.
8. Hoogervost ELJ, Kalkers NF, van Wiesen LML, Uitdehaag BMJ, Polman CH. Differential treatment effect on measures of neurological exam, functional impairment and patient self-report. Mult Scler 2001; 7: 335-39.
9. Uitdehaag BMMJ, Ader HJ, Kalkers NF, Polmann CH. Quantitative functional measure in MS: What is a reliable change? Letter to the editor. Neurology 2002; 59: 648-49.
10. Alusi SH, Worthington J, Glickman S, Findley LJ, Bain PG. Evaluation of three different ways of assessing tremor in multiple sclerosis. J Neurol Neurosurg Psychiatry 2000; 68: 756-60.
11. Goodkin DE, Rudick RA, VanderBrug Medendorp S, Daughtry MM, Schwetz KM, Fisher J et al. Low dose (7.5 mg) oral methotrexate reduces the rate of progression in chronic progressive multiple sclerosis. Ann Neurol 1995; 37: 30-40.
12. Wade DT. Measurement in neurological rehabilitation. Oxford: Oxford University Press, 1992.
13. Vaney C, Blaurock H, Gattlen B, Meisels C. Assessing mobility in multiple sclerosis using the Rivermead Mobility Index and gait speed. Clin Rehab 1996; 10: 216-26.
14. Schwid SR, Goodmann AD, Mattson DH, Mihai C, Donhoe KM, Petrie MD. The measurement of ambulatory impairment in multiple sclerosis. Neurology 1997; 49: 1419-24.
15. Schwid SR, Goodmann AD, McDermott MP, Bever CF, Cook SD. Quantitative functional measures in MS: what is a reliable change? Neurology 2002; 58: 1294-96.
16. Collen FM, Wade DT, Robb GF, Bradshaw CM. The Rivermead Mobility Index: a further development of the Rivermead Motor Assessment. Int Disabil Stud 1991; 13: 50-54.
17. Fischer JS, Jak AJ, Knicker JE, Rudick RA, Cutter G. Administration and scoring manual for the multiple sclerosis functional composite (MSFC). New York: Demos, 1999.
18. Mathiowetz V, Weber K, Kashmann N, Volland G. Adult norms for the nine-hole peg test of manual dexterity. Am J Occup Therapy 1985; 5: 24-37.
19. Granger CV, Hamilton BB, Sherwin FS. Guide for the use of the uniform data set for medical rehabilitation. Uniform Data System for Medical Rehabilitation Project Office, Buffalo General Hospital, New York, USA, 1986.
20. Nouri FM, Lincoln NB. An extended activities of daily living scale for stroke patients. Clin Rehabil 1991; 1: 301-305.
21. Demeurisse G, Demol O, Robaye E. Motor evaluation in vascular hemiplegia. Eur Neurol 1980; 19: 382-89.
22. Perry J, Garett M, Gronley JAK, Mulroy SJ. Classification of walking handicap in the stroke population. Stroke 1995; S26: 982-89.
23. Katzman R, Brown T, Fuld P, Peck A, Schechter R, Schimmel H. Validation of a short Orientation-Memory - concentration test of cognitive impairment. Am J Psychiatry 1983; 140: 734-39.
24. Hoogervost ELJ, Eikelenboom MJ, Uitdehaag BMJ, Polman CH. One year changes in disability in multiple sclerosis: neurological examination compared with patient self report. JNNP 2003; 74: 439-42.
25. Cohen JA, Cutter GR, Fisher JS, Goodman AD, Heidenreich FR, Jak AJ et al. Use of the MSFC as an outcome measure in the phase 3 clinical trial. Arch Neurol 2001; 58:961-67.
26. Provinciali L, Ceravo MG, Bartolini M, Logullo F, Danni M. A multidimensional assessment of multiple sclerosis: relationship between disability domains. Acta Neurol Scand 1999; 100: 156-62.
27. Wiles CM, Newcombe RG, Fuller KJ, Shaw S, Furnival-Doran C, Pickersgill TP et al. Controlled randomised crossover trial of the effects of physiotherapy on mobility in chronic multiple sclerosis. J Neurol Neurosurg Psychiatry 2001; 70: 174-79.